Weilong shares: it is proposed to transfer 49% equity of Jiju electromechanical with RMB 24.5 million
Financial Associated Press, Dec. 10 - Weilong announced that the company plans to transfer 49% of the equity of its wholly-owned subsidiary Qingdao Jiju electromechanical Co., Ltd. ("Jiju electromechanical") to LV Renhong, the transferee, at a transfer price of 24.5 million yuan. After the equity transfer, the company will hold 51% of the equity of juelectromechanical. This equity transfer does not involve changes in the scope of consolidated statements, that is, juelectromechanical is still the holding subsidiary of the company.
This text is a result of machine translation.
Related companies：
Briefing Jan 17, 2022 07:30 PM
· Technology
Dahu shares: it is proposed to transfer 54.67% equity of East Lake company to Xinyuan agriculture of Huarong County for 1 yuan
In-depth
Technology
Successful Multinational Corporations in China Series: Qualcomm China
Since China's reform and opening-up, many multinational corporations and groups have achieved success in China. They have not only been successful in their fields, but some also benefitted from wise M&A moves or investments. To answer these questions EqualOcean launches its Successful Multinational Corporations in China and analyzes the critical points of investing in China for investors and people interested in such a topic.
Yesterday 02:02 PM
Briefing Dec 31, 2021 10:18 AM
The raw materials department of the Ministry of industry and information technology will carry out green building materials to the countryside on a pilot basis
May 02, 2022 07:50 PM
Apr 18, 2022 09:14 PM
Apr 18, 2022 06:30 PM
Apr 11, 2022 08:42 PM
Briefing Dec 29, 2021 12:29 PM
The regulations of Guangzhou Airport Economic Zone will be officially implemented next year
Briefing Dec 13, 2021 07:40 PM
Tongda Co., Ltd.: pre winning the bidding procurement project of national home appliance network of 111 million yuan
In-depth
Healthcare
BeiGene: a Vast Opportunity Lies Ahead – But We Remain Cautious
BeiGene, a leader in China's novel pharmaceutical industry, recently received approval in Kuwait, Bahrain, and Qatar for its medication BRUKINSA (zanubrutinib). Previous contracts with major biopharma have produced substantial licensing income, but they did not lessen BeiGene's financial burden.
Jun 24, 2022 12:13 PM
Briefing Dec 13, 2021 11:59 AM
· Financials
Ministry of transport: improve the cold chain logistics infrastructure network and promote the upgrading of cold chain transportation technology and equipment
Briefing Dec 11, 2021 10:19 PM
· Technology
Server sales of Xinhua III in the third quarter increased by 35.1% year-on-year
Briefing Nov 27, 2021 09:38 PM
· Technology
Ziguang Co., Ltd.: its Xinhua Group won the bid for China Mobile PC server centralized purchase project
Briefing Nov 09, 2021 08:28 PM
· Technology
Hong Kong's electricity tariff hike next year to cope with soaring global fuel prices
See more
Read next
In-depth
EqualOcean is an information service provider and investment research company that aims to become a global platform for industrial innovation. Founded in February 2014 and headquartered in Beijing, with a client network covering over 50 countries, the firm provides comprehensive professional services, including industry research, investment analysis, innovation consulting, data products, corporate branding and international strategy.